ATE431835T1 - Verfahren zum schutz von thiolgruppen in antikörpern - Google Patents

Verfahren zum schutz von thiolgruppen in antikörpern

Info

Publication number
ATE431835T1
ATE431835T1 AT03780938T AT03780938T ATE431835T1 AT E431835 T1 ATE431835 T1 AT E431835T1 AT 03780938 T AT03780938 T AT 03780938T AT 03780938 T AT03780938 T AT 03780938T AT E431835 T1 ATE431835 T1 AT E431835T1
Authority
AT
Austria
Prior art keywords
antibodies
thiol groups
protecting thiol
protecting
protein
Prior art date
Application number
AT03780938T
Other languages
English (en)
Inventor
Kenji Sasaki
Yasuhiko Katsumura
Original Assignee
Mitsubishi Tanabe Pharma Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mitsubishi Tanabe Pharma Corp filed Critical Mitsubishi Tanabe Pharma Corp
Application granted granted Critical
Publication of ATE431835T1 publication Critical patent/ATE431835T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/06—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length using protecting groups or activating agents
    • C07K1/061—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length using protecting groups or activating agents using protecting groups
    • C07K1/066—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length using protecting groups or activating agents using protecting groups for omega-amido functions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/006—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length of peptides containing derivatised side chain amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • C07K1/1072—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups
    • C07K1/1077—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups by covalent attachment of residues other than amino acids or peptide residues, e.g. sugars, polyols, fatty acids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Analytical Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT03780938T 2002-12-20 2003-12-19 Verfahren zum schutz von thiolgruppen in antikörpern ATE431835T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2002370822 2002-12-20
PCT/JP2003/016362 WO2004056872A1 (ja) 2002-12-20 2003-12-19 タンパク質のチオール基を保護する方法

Publications (1)

Publication Number Publication Date
ATE431835T1 true ATE431835T1 (de) 2009-06-15

Family

ID=32677181

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03780938T ATE431835T1 (de) 2002-12-20 2003-12-19 Verfahren zum schutz von thiolgruppen in antikörpern

Country Status (9)

Country Link
US (1) US20060257393A1 (de)
EP (1) EP1574521B1 (de)
JP (1) JPWO2004056872A1 (de)
AT (1) ATE431835T1 (de)
AU (1) AU2003289455A1 (de)
CA (1) CA2511228A1 (de)
DE (1) DE60327715D1 (de)
ES (1) ES2326076T3 (de)
WO (1) WO2004056872A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR103172A1 (es) 2014-12-22 2017-04-19 Novartis Ag Reducción selectiva de residuos de cisteina en anticuerpos il-17
AR103173A1 (es) 2014-12-22 2017-04-19 Novarits Ag Productos farmacéuticos y composiciones líquidas estables de anticuerpos il-17

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4734362A (en) * 1986-02-03 1988-03-29 Cambridge Bioscience Corporation Process for purifying recombinant proteins, and products thereof
ES2064336T3 (es) * 1987-10-13 1995-02-01 Thomae Gmbh Dr K Procedimiento para la preparacion de proteinas.
US5130418A (en) * 1989-05-02 1992-07-14 California Biotechnology Inc. Method to stabilize basic fibroblast growth factor
AU660001B2 (en) * 1990-10-25 1995-06-08 Trustees Of Columbia University In The City Of New York, The Development of DNA probes and immunological reagents of human tumor associated antigens
US5284830A (en) * 1991-02-13 1994-02-08 The Board Of Trustees Of The Leland Stanford Junior University Thyroid-derived chondrocyte-stimulating factor
JP3220180B2 (ja) * 1991-05-23 2001-10-22 三菱化学株式会社 薬剤含有タンパク質結合リポソーム
CA2072249C (en) * 1991-06-28 2003-06-17 Saiko Hosokawa Human monoclonal antibody specifically binding to surface antigen of cancer cell membrane
JP3236667B2 (ja) * 1991-06-28 2001-12-10 三菱化学株式会社 ヒト型モノクローナル抗体およびそれをコードする遺伝子、ハイブリドーマ並びに抗腫瘍剤
FI950062A7 (fi) * 1992-07-06 1995-01-05 Biomira Inc Proteiinien foroaktivaatio konjugaatiotarkoituksia varten
EP0943690B1 (de) * 1995-12-21 2006-11-29 Ajinomoto Co., Inc. Verfahren zur rückfaltung von menschlichem activin a
AU714318B2 (en) * 1996-06-11 2000-01-06 Roche Diagnostics Gmbh Process for the activation of denatured protein
WO2001075095A1 (fr) * 2000-03-30 2001-10-11 Takeda Chemical Industries, Ltd. Procede de production de proteine de recombinaison
WO2003048357A1 (fr) * 2001-12-04 2003-06-12 Mitsubishi Pharma Corporation Procede d'activation de proteine

Also Published As

Publication number Publication date
US20060257393A1 (en) 2006-11-16
EP1574521A4 (de) 2006-04-12
AU2003289455A1 (en) 2004-07-14
EP1574521A1 (de) 2005-09-14
JPWO2004056872A1 (ja) 2006-04-20
ES2326076T3 (es) 2009-09-30
DE60327715D1 (de) 2009-07-02
EP1574521B1 (de) 2009-05-20
WO2004056872A1 (ja) 2004-07-08
CA2511228A1 (en) 2004-07-08

Similar Documents

Publication Publication Date Title
ATE392430T1 (de) Verfahren zur herstellung von dipeptiden
NO2020016I1 (no) efmoroktokog alfa - forlenget SPC
DE60308525D1 (de) Verfahren zur herstellung einer rasch erstarrten legierung für magnete
DE60336768D1 (de) Dichtpatrone für eine Raupenkette
DE60330541D1 (de) System zum Verfolgen von Poststücken
DE60335733D1 (de) Verfahren zur solubilisierung von protein
AU2003250825A8 (en) Inhibitors of glycoprotein vi
DE602004026912D1 (de) Formulierungen und verfahren zum denaturieren von proteinen
ATE348043T1 (de) Verfahren zum fördern von beuteln.
TW200518759A (en) Anti-infective agents
DK0967703T3 (da) Anordning af fastgörelseselementer til at holde bundter omspændt med kabelbindere
DE50303241D1 (de) Verfahren zur bereitstellung von abwesenheitsinformation
PE20040703A1 (es) Derivados aldehido de polietilenglicol
EA200600042A1 (ru) Способы образования дисульфидных связей и гликозилирования белков и реагенты, применяемые в этих способах
DE50310109D1 (de) Verfahren zum einfärben von düngemitteln
DE60327715D1 (de) Verfahren zum schutz von thiolgruppen in antikörpern
DE60316234D1 (de) Verfahren zum Schutz von Artikeln, und entsprechende Zusammensetzungen
DE60201984D1 (de) Werkzeugstahl von hoher zähigkeit, verfahren zum herstellen von teilen aus diesem stahl und so hergestellte teile
EP1533296A4 (de) Sulfenylverbindung, markierungsreagens und verfahren zur analyse von peptid
DK0914605T3 (da) Molekylemodel for VLA-4-inhibitorer
DE60333893D1 (de) Verfahren und System zum Etikettieren von Postsendungen
ATE356670T1 (de) Verfahren zur aufbereitung von sulfidmineralien
ATE391559T1 (de) Vorrichtung zur behandlung von werkstücken
DE10344113A1 (de) Vorrichtung und Verfahren zum Verbinden von Wafern
DE69918708D1 (de) Verfahren zum fixieren von bio-molekülen an eine probestelle

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties